Leavitt Chase C.

CIK 00017774673 companiesAUSTIN, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001777467

Recent Transactions

31 trades

Purchase
Mobia Medical, Inc.$MOBI
Common Stock
2026-09-11$10.30/sh+2,000→ 5,000 total
Purchase
Mobia Medical, Inc.$MOBI
Common Stock
2026-05-11$15.00/sh+3,000→ 3,000 total
Award
Mobia Medical, Inc.$MOBI
Stock Option
2026-05-07+175,760→ 175,760 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2024-02-14+14,200→ 14,200 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2024-01-03$0.50/sh−11,838→ 84,758 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−210,000→ 0 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−28,750→ 0 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−55,519→ 0 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−65,000→ 0 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+55,519→ 55,519 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+235,000→ 235,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+210,000→ 210,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+28,750→ 28,750 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+65,000→ 65,000 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2023-07-03$0.36/sh−10,305→ 96,596 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2023-04-13$0.29/sh+10,000→ 106,901 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2023-04-12$0.29/sh+15,000→ 96,901 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-02-21+210,000→ 210,000 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2023-01-03$1.02/sh−6,091→ 81,901 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2022-07-28+28,750→ 28,750 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2022-07-28+43,125→ 87,992 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2022-01-28$1.63/sh+5,000→ 44,867 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2022-01-27$1.78/sh+8,500→ 39,867 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2022-01-20+55,519→ 55,519 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2022-01-03+29,867→ 31,367 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2021-06-11$5.45/sh+1,500→ 1,500 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Employee Stock Option (Right to Buy)
2021-03-15+699,100→ 699,100 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Employee Stock Option (Right to Buy)
2020-03-17+616,700→ 616,700 total
Purchase
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares
2019-08-13$1.02/sh+5,000→ 5,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Employee Stock Option (Right to Buy)
2019-07-31+125,000→ 125,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Employee Stock Option (Right to Buy)
2019-05-20+300,000→ 300,000 total

Companies

Recent Filings

Address

2802 FLINTROCK TRACE, SUITE 226

AUSTIN, TX, 78738

View on SEC.gov